Exagen News

Buy Rating Affirmed for Exagen on Strong Financials and Strategic Growth Initiatives

TipRanksMar 20 17:56

Exagen's Strong Q4 Performance and Positive Outlook Justify Buy Rating

TipRanksMar 19 07:05

Exagen (XGN) Receives a Buy From BTIG

TipRanksJan 2 22:55

Exagen (XGN) Gets a Buy From BTIG

TipRanksDec 31, 2023 18:28

Exagen (XGN) Gets a Buy From Cantor Fitzgerald

TipRanksNov 14, 2023 20:58

Analysts Offer Insights on Healthcare Companies: Exagen (XGN) and Milestone Pharmaceuticals (MIST)

TipRanksNov 14, 2023 10:30

Cantor Fitzgerald Reiterates Overweight on Exagen, Maintains $6 Price Target

BenzingaSep 27, 2023 00:02

Exagen Analyst Ratings

BenzingaSep 27, 2023 00:01

Cantor Fitzgerald Reiterates Overweight on Exagen, Maintains $6 Price Target

BenzingaAug 22, 2023 23:55

Exagen Analyst Ratings

BenzingaAug 22, 2023 23:54

Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN)

TipRanksMay 17, 2023 00:25

Cantor Fitzgerald Reiterates Overweight on Exagen, Maintains $6 Price Target

BenzingaMay 16, 2023 20:39

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Exagen (XGN)

TipRanksMay 16, 2023 19:10

BTIG Adjusts Price Target on Exagen to $5 From $6, Maintains Buy Rating

MT NewswiresMar 22, 2023 20:48

BTIG Maintains Buy on Exagen, Lowers Price Target to $5

BenzingaMar 22, 2023 20:17

BTIG Keeps Their Buy Rating on Exagen (XGN)

TipRanksMar 22, 2023 09:31

BTIG Adjusts Exagen's Price Target to $7 From $10, Keeps Buy Rating

MT NewswiresNov 17, 2022 21:19

Exagen Analyst Ratings

Benzinga Analyst RatingsNov 17, 2022 20:06

Canaccord Genuity Cuts Price Target on Exagen to $7 From $8, Affirms Buy Rating

MT NewswiresNov 15, 2022 22:02

Exagen Analyst Ratings

Benzinga Analyst RatingsNov 15, 2022 20:37